Medicare Enrolled
Dr. Vaqar Siddiqui, MD
Neurology · Eastpointe, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Siddiqui from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Siddiqui?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Siddiqui
Dr. Vaqar Siddiqui is a neurology specialist in Eastpointe, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Siddiqui performed 1,900 Medicare services across 1,110 unique beneficiaries.
Between the years covered by Open Payments, Dr. Siddiqui received a total of $14,049 from 45 pharmaceutical and/or device companies across 835 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Siddiqui is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 9% volume in MI
$14,049 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,900
Medicare services
Top 9% in MI for neurology
1,110
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~95 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
980 | $66 | $125 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
232 | $144 | $305 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
152 | $108 | $245 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
114 | $99 | $155 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
109 | $62 | $130 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
48 | $78 | $200 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
42 | $358 | $655 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
42 | $99 | $175 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
36 | $133 | $289 |
| Emergency department visit, low level of medical decision making An emergency department visit for a patient requiring a low level of medical decision making. |
28 | $61 | $200 |
| Annual depression screening | 18 | $19 | $30 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
17 | $172 | $370 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
17 | $70 | $225 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
16 | $292 | $625 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
14 | $42 | $120 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $148 | $190 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
11 | $143 | $320 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
11 | $179 | $380 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,049
Total received (2018-2024)
Avg $2,007/year across 7 years
Top 19% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
835
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,037 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,082
2023
$2,146
2022
$2,058
2021
$1,857
2020
$1,419
2019
$2,969
2018
$1,518
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$679
Biogen, Inc.
$335
Neurelis, Inc.
$212
PFIZER INC.
$167
SK Life Science, Inc.
$123
Lilly USA, LLC
$96
Sumitomo Pharma America, Inc.
$90
Novartis Pharmaceuticals Corporation
$84
EMD Serono, Inc.
$76
CATALYST PHARMACEUTICALS, INC.
$43
Teva Pharmaceuticals USA, Inc.
$41
Eisai Inc.
$38
Kyowa Kirin, Inc.
$35
Aucta Pharmaceuticals, Inc.
$18
ABBVIE INC.
$16
MITSUBISHI TANABE PHARMA AMERICA, INC.
$15
Celgene Corporation
$13
Top 3 companies account for 58.9% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$2,642
UCB, Inc.
$2,392
Novartis Pharmaceuticals Corporation
$1,153
SK Life Science, Inc.
$669
Neurelis, Inc.
$605
EMD Serono, Inc.
$574
Sunovion Pharmaceuticals Inc.
$549
EISAI INC.
$423
Amgen Inc.
$410
Lilly USA, LLC
$406
Teva Pharmaceuticals USA, Inc.
$359
Supernus Pharmaceuticals, Inc.
$347
Eisai Inc.
$344
GENZYME CORPORATION
$332
Celgene Corporation
$322
PFIZER INC.
$266
Genentech USA, Inc.
$265
Avanir Pharmaceuticals, Inc.
$218
Lundbeck LLC
$206
Medtronic Vascular, Inc.
$179
Greenwich Biosciences, Inc.
$153
Biohaven Pharmaceutical Holding Company Ltd.
$146
Sumitomo Pharma America, Inc.
$121
Amneal Pharmaceuticals LLC
$109
Alexion Pharmaceuticals, Inc.
$105
Kyowa Kirin, Inc.
$89
E.R. Squibb & Sons, L.L.C.
$89
Corium, LLC
$81
MITSUBISHI TANABE PHARMA AMERICA, INC.
$62
Biohaven Pharmaceuticals, Inc.
$61
JAZZ PHARMACEUTICALS INC.
$57
Catalyst Pharmaceuticals, Inc.
$46
CATALYST PHARMACEUTICALS, INC.
$43
ABBVIE INC.
$35
Horizon Therapeutics plc
$27
Alnylam Pharmaceuticals Inc.
$25
Bausch Health US, LLC
$24
Aucta Pharmaceuticals, Inc.
$18
Allergan Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$14
Strongbridge US INC.
$14
Zogenix Inc.
$13
Circassia Pharmaceuticals Inc
$12
Allergan, Inc.
$12
Top 3 companies account for 44.0% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BOTOX THERAPEUTIC · Banzel · Betaseron · Briviact · COLOGUARD · COMIRNATY · EMGALITY · EPIDIOLEX · Epidiolex · FYCOMPA · Fintepla · Fycompa · GILENYA · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · Motpoly XR · NORTHERA · NUEDEXTA · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · ONFI · ONPATTRO · OXTELLAR XR · Ocrevus · PLEGRIDY · QULIPTA · RADICAVA · RYTARY · Reveal LINQ · Rystiggo · SOLIRIS · SPINRAZA · Superion · TECFIDERA · TROKENDI XR · TUDORZA PRESSAIR · TYSABRI · UBRELVY · UPLIZNA · VALTOCO · VUMERITY · VYEPTI · Vimpat · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
266
Per 100K population
30.3
County median income
$76,399
Nearest hospital
BCA STONECREST CENTER
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Siddiqui is a mixed practice specialist, with above-average Medicare volume (top 9% in MI), with low-engagement industry engagement in the top 19% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Siddiqui experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Siddiqui performed 980 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Siddiqui receive payments from pharmaceutical companies?
Yes. Dr. Siddiqui received a total of $14,049 from 45 companies across 835 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Siddiqui's costs compare to other neurologists in Eastpointe?
Dr. Siddiqui's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Siddiqui) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Eastpointe
Browse neurologists in Eastpointe ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in MI
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in MI
Which MI neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology